Zambon Spa
Clinical trials sponsored by Zambon Spa, explained in plain language.
-
Inhaled therapy tested to fight lung transplant rejection
Disease control CompletedThis study tested whether adding an inhaled form of the drug cyclosporine (L-CsA) to standard care could better preserve lung function in adults who had received a double lung transplant and developed chronic rejection (CLAD-BOS). 169 participants were randomly assigned to receiv…
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Inhaled therapy tested to halt lung transplant failure
Disease control CompletedThis study tested whether adding an inhaled form of the drug cyclosporine (L-CsA) to standard care could better treat chronic rejection in single lung transplant patients. 62 adults who had received a transplant at least a year prior and were experiencing declining lung function …
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
IV Mucus-Busters show promise for easier breathing
Symptom relief CompletedThis study tested if two intravenous (IV) drugs could help adults with lung diseases like bronchitis who have trouble coughing up thick mucus. About 333 hospitalized patients in China received either N-acetylcysteine (NAC), ambroxol, or a placebo for one week. The main goal was t…
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Symptom relief
Last updated Mar 17, 2026 13:09 UTC